Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapy.

Japanese Journal of Ophthalmology
Kenji Kashiwagi

Abstract

To prospectively assess the efficacy of switching to a travoprost/timolol fixed-combination (TTFC) therapy from latanoprost monotherapy. This was a prospective, open-label study in which patients with either primary open-angle glaucoma or ocular hypertension who had been undergoing latanoprost monotherapy for at least 3 months were enrolled. Baseline was defined as the time when the subjects were started on latanoprost monotherapy. Examination periods were defined as 1, 2, and 3 months the switch to TTFC therapy, and 1-2 months after the switch back to latanoprost monotherapy. The parameters examined were intraocular pressure (IOP), conjunctival hyperemia, and corneal erosion, as well as blood pressure and heart rate. A survey was conducted 1 and 3 months after the switch to TTFC therapy with a focus on each subject's impressions. Among the 70 enrolled subjects, the 58 (29 men, 29 women) who completed the protocol were analyzed. The IOP before and at 1, 2, and 3 months after the switch to TTFC therapy was measured and again after the switch back to latanoprost monotherapy. The results indicated that TTFC therapy significantly reduced the IOP (P < 0.001) and significantly decreased the heart rate, but it did not significantly ch...Continue Reading

References

Oct 9, 2001·American Journal of Ophthalmology·P A NetlandUNKNOWN Travoprost Study Group
Apr 25, 2002·Nursing Standard·J P Snape, A Waldock
Sep 15, 2004·American Journal of Ophthalmology·John H K LiuRobert N Weinreb
Jan 12, 2005·Archives of Ophthalmology·Stefano A GandolfiMaria Grazia Tardini
Jul 2, 2005·American Journal of Ophthalmology·Howard S BarnebeyMichael V W Bergamini
Aug 26, 2006·Drugs & Aging·Sheridan M HoyGillian M Keating
Mar 14, 2007·Drugs of Today·Robert J NoeckerMalik Y Kahook
Aug 10, 2007·American Journal of Ophthalmology·Alan L RobinTania S Marcic
Apr 2, 2008·Expert Opinion on Pharmacotherapy·Michael Herceg, Robert Noecker
Mar 20, 2009·Journal of Glaucoma·Fawzia DjafariJean Lachaine
Nov 6, 2010·Japanese Journal of Ophthalmology·Sung Woo ChoChul Young Choi
Jan 12, 2011·Archives of Ophthalmology·Desmond T L QuekTin Aung

❮ Previous
Next ❯

Citations

Dec 13, 2012·Japanese Journal of Ophthalmology·Rei SakataMakoto Aihara
Jan 11, 2014·Japanese Journal of Ophthalmology·Kenji Kashiwagi, Toshie Furuya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.